Connect with us

Featured

Stocks & Real Estate Are At All Time Highs. Where’s A Good Place To Invest?

Joe Samuel

Published

on

real estate stocks

Interest rates are on the rise, the dollar is strengthening, trade wars are looming and we’re beginning to see more volatility across markets. Furthermore, institutional investors are changing their risk profiles and adjusting dramatically toward debt investments. As part of this adjustment, investors are now sending money into private debt as a means to protect themselves from an anticipated market correction while still earning stable returns. According to Preqin, private debt funds raised a record $107 billion last year.

With such volume of cash hurling into private debt, it can be difficult to identify value. One private debt sector that may be attractive to institutional investors is commercial real estate (CRE), which offers the potential for both diversification and an attractive risk-return profile at this late stage of a nearly decade-long bull run.

Many signs are beginning to point to a top in the market, and investors are starting to look for cover. Since 2015 the Fed has been lifting its key policy rate from historic lows, elevating interest rates and bringing a period of loose monetary policy and easy credit to an end. Though increasing, bond yields remain lower, and many returns on higher-rated debt securities remain generally modest.

Institutions looking to send money in CRE can typically decide between equity and debt vehicles, each of which comes with its advantages and disadvantages based on where the market is in the cycle. Early in the cycle, as CRE property values rise, allocating more toward equity instruments makes sense. Here, investors can buy a property outright or purchase stock in firms that specialize in CRE. They can also invest in mutual funds or exchange-traded funds that provide equity exposure to CRE.

With prices peaking, CRE debt vehicles can offer a more secure option, and an attractive middle ground between volatile stocks and zero-interest savings accounts, efficiently balancing risk and returns while providing consistent cash flow to a portfolio. Many CRE debt instruments offer the added benefit of short-term duration, allowing institutions to “roll up” the yield curve as rates rise.

Industry participants predict multifamily and industrial assets will hold the most appeal through 2018, according to a survey my firm conducted at a recent Mortgage Bankers Association convention. Lesser-known yet promising assets include student housing, senior housing, health care offices, medical facilities, laboratories, data centers, and even cold storage. Geographically, institutional investors can get exposure to opportunities that prioritize noncore, second-tier cities, particularly those away from the coasts, such as Dallas, Texas; Nashville, Tennessee; and Charlotte, North Carolina, which offer exceptional opportunities for growth.

Each of these factors suggests that the CRE market can weather the coming volatility, and that fixed-income investment vehicles with CRE exposure will continue to be a source of stable returns and risk mitigation for institutional investors.

Continue Reading
Click to comment

Featured

Stock Price Newsletter – November 21, 2019

Joe Samuel

Published

on

stock price newsletter

Is The Entertainment Streaming Market Ready For Its Next Move?

As many experts have pointed out, the end of 2019 is going to see the commencement of the ‘streaming wars’ as more and more companies enter the OTT market to challenge the supremacy of Netflix Inc (NASDAQ: NFLX). The launch of the streaming service Disney Plus last week formally launched the streaming wars.

Click Here To Read More


Biotech Names To Know In November 2019

Over the years, the biotech sector has become one of the fastest-growing sectors in the stock market and naturally, investors are keen to get hold of stocks that could follow a similar growth trajectory. However, just because a sector is growing does not mean that an investor can bet on any stock and hope to make decent returns.


3 Defense Stocks to Watch in November

Over the years it has become abundantly clear that defense spending is going to rise every year and hence, defense stocks have naturally emerged as some of the safest investments in the market. However, the current unstable geopolitical situation in different corners of the world could lead to even more defense spending, if a Bank of America analyst is to be believed.

See For Yourself

Continue Reading

Biotechnology

Biotech Names To Know In November 2019

A. Lawrence

Published

on

best biotechnology stocks to buy sell

Biotech Stocks Have rallied since The End Of September; What’s Next?

Over the years, the biotech sector has become one of the fastest-growing sectors in the stock market and naturally, investors are keen to get hold of stocks that could follow a similar growth trajectory. However, just because a sector is growing does not mean that an investor can bet on any stock and hope to make decent returns.

In order to choose the right stock, he needs to do a lot of personal research and watch the market closely. Here is a look at three biotech stocks that investors should track closely owing to recent developments.

Sernova Corp’s (TSX:SVA) (OTC:SEOVF)

Sernova’s therapeutic approach to regenerative medicine focuses on providing direct cell therapies where the cells, transplanted within an organ-like vascularized implantable device, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

The company’s Cell Pouch is a novel, proprietary, scalable, implantable macro-encapsulation device designed for the long- term survival and function of therapeutic cells. At the end of October Sernova Corp. (SVA) (SEOVF) detected enduring levels of C-peptide in the bloodstream of a fasting patient in its continuing phase I/II Cell Pouch United States clinical study of type-1 diabetes. This C-peptide is a biomarker of transplanted beta-cell insulin production,

Why is this important? According to Dr. Piotr Witkowski, Director of Pancreatic, and Islet Transplant Program at the University of Chicago, “Along with the preliminary safety and early indicators of efficacy, I am excited that we are observing C-peptide levels in the patient’s bloodstream after recent transplant, not only following stimulation with a meal but also when the patient is fasting. These findings represent progress in clinical outcomes and evidence of enduring islet survival and function within Sernova’s Cell Pouch.”

Read This Full Press Release Here

Genprex (GNPX)

The first one to put in the watch list is that of Genprex Inc (NASDAQ:GNPX). On Tuesday, the company revealed preclinical data from its study of its product TUSC2 immunogene therapy. The product in question is meant for raising the effectiveness of chemotherapy and anti-PD1 in people suffering from metastatic lung cancers.

The data proved to be positive and that has naturally resulted in a rally in the stock. It is a significant development for Genprex and could potentially help the company in cornering an important portion of the gene therapy market. Hence, it is hardly a surprise that the stock has rallied by as much as 60% after hitting a session’s high of $1.09.

 Can Fite Biopharma (CANF)

The other biotech stock that has made a strong move is the Can Fite Biopharma (NYSE:CANF) stock. The biotech company announced this morning that one of its products, which is meant for the treatment of liver diseases and cancer, has been granted a patent as a sexual dysfunction medicine.

The patents have been granted by the relevant authorities in Canada, Israel, and South Korea. In addition to that, the company has also been awarded patents in Japan, China, United States, Australia, and Hong Kong. It is a highly important development for Can-Fite and it was no surprise when the stock rallied this morning. It has rallied by 3% on Tuesday on the back of the news.

top biotech stocks to watch list

Disclaimer: Pursuant to an agreement between Midam Ventures LLC and Sernova (TSX:SVA) (OTC:SEOVF), Midam has been paid $350,000 for a period from September 23, 2019 to September 22, 2020. We may buy or sell additional shares of Sernova (TSX:SVA) (OTC:SEOVF) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Sernova (TSX:SVA) (OTC:SEOVF). Click Here For Full Disclaimer.

Continue Reading

Entertainment

Is The Entertainment Streaming Market Ready For Its Next Move?

A. Lawrence

Published

on

streaming wars netflix apple hulu disney

New Streaming Options Have Opened A Big Door For Content Providers

As many experts have pointed out, the end of 2019 is going to see the commencement of the ‘streaming wars’ as more and more companies enter the OTT market to challenge the supremacy of Netflix Inc (NASDAQ:NFLX). The launch of the streaming service Disney Plus last week formally launched the streaming wars.

Do Content Providers Stand To Benefit?

According to an article published on Reuters the global video streaming market was valued at $26.27 billion in 2015 and is expected to reach $83.41 billion by 2022 growing at a CAGR of 17.9% from 2015 to 2022. Apple, Disney, Netflix, Amazon, NBC, Hulu & more are all competing within the global video streaming market and they all need the same thing… new & original content. Massive demand may create a huge opportunity for companies like Fearless Films (FERL).

Fearless Films is an independent full-service production company. This is the exact type of company that can benefit from what could become one of the biggest cash grabs in entertainment history and here’s why. You’ve likely heard of the big production houses: Warner Bros, DreamWorks, Red Crown Productions and others who benefited from big deals with streaming companies.

It isn’t just Netflix who’s flexing billions in content budgets, Apple, Amazon, Disney, NBC, Roku – the list goes on. These are huge entertainment distributors who are now fighting for one thing… Where you spend your waking hours streaming entertainment.

Click To Read More On Fearless Films (FERL)

Key Analysis On Streaming Service Providers

Considering the fact that the new service has already garnered 10 million users, it’s fair to say that it is here to say. Considering the fact that Apple has already launched its own service and many other services are going to be launched in the next few months, experts are now wondering whether the streaming space has become too crowded.

The success of Game of Thrones has ushered in an era of unprecedented spending for quality content. The show generated total profit to the tune of $2.2 billion for HBO, which is owned by AT&T. Hence, video streaming companies have also decided to spend jaw-dropping sums on original content. Apple has earmarked $6 billion for original content, while Disney is expected to match that.

streaming cord cutting entertainment stocks

Both companies are trying to create that one show that could turn into a cash cow. On the other hand, Apple is going to price is monthly subscription at $4.99 and Disney is going to charge $6.99 for the same. In such a situation, one can expect Netflix to change tack since its cheapest subscription is worth $12.99.

So, the crowding is quite apparent as mega corporations enter the streaming space. However, the question remains whether the business is going to grow and new subscribers are going to flock in. Studies suggest that it will grow and up until 2024, the streaming market should grow by 18.8% each year. In 2024, the market is going to be worth $687 billion. Hence, it is quite clear that despite the intense competition that is going to come to the streaming space, there is still room for companies to grow and become profitable.

apple tv cord cutting AAPL stock

Disclaimer: Pursuant to an agreement between Midam Ventures LLC and Fearless Films Inc. (FERL), Midam has been paid $94,980 by Fearless Films Inc. (FERL) for a period from October 1, 2019 to November 17, 2019. We may buy or sell additional shares of Fearless Films Inc. (FERL) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Fearless Films Inc. (FERL). Click Here For Full Disclaimer.

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


Privacy Policy

We keep all user information pricate & promise to never spam.*

Stock Price Free Text List

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com